Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides

Two cell entry mechanisms cooperate in peptide-mediated intracellular delivery. Cell-penetrating peptides (CPPs) have been widely used to deliver nanomaterials and other types of macromolecules into mammalian cells for therapeutic and diagnostic use. Cationic CPPs that bind to heparan sulfate (HS) proteoglycans on the cell surface induce potent endocytosis; however, the role of other surface receptors in this process is unclear. We describe the convergence of an HS-dependent pathway with the C-end rule (CendR) mechanism that enables peptide ligation with neuropilin-1 (NRP1), a cell surface receptor known to be involved in angiogenesis and vascular permeability. NRP1 binds peptides carrying a positive residue at the carboxyl terminus, a feature that is compatible with cationic CPPs, either intact or after proteolytic processing. We used CPP and CendR peptides, as well as HS- and NRP1-binding motifs from semaphorins, to explore the commonalities and differences of the HS and NRP1 pathways. We show that the CendR-NRP1 interaction determines the ability of CPPs to induce vascular permeability. We also show at the ultrastructural level, using a novel cell entry synchronization method, that both the HS and NRP1 pathways can initiate a macropinocytosis-like process and visualize these CPP-cargo complexes going through various endosomal compartments. Our results provide new insights into how CPPs exploit multiple surface receptor pathways for intracellular delivery.

[1]  C. Perou,et al.  "Synchronized" endocytosis and intracellular sorting in alveolar macrophages: the early sorting endosome is a transient organelle , 1995, The Journal of cell biology.

[2]  M. Tessier-Lavigne,et al.  Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III , 1997, Cell.

[3]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[4]  G. Camussi,et al.  HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment , 2001, The Journal of Immunology.

[5]  M. Giacca,et al.  Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[6]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[7]  M. Johansson,et al.  Cell surface adherence and endocytosis of protein transduction domains. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. Hori,et al.  Glycosaminoglycan modification of neuropilin‐1 modulates VEGFR2 signaling , 2006, The EMBO journal.

[10]  L. Ellis The role of neuropilins in cancer , 2006, Molecular Cancer Therapeutics.

[11]  S. Dowdy,et al.  TAT transduction: the molecular mechanism and therapeutic prospects. , 2007, Trends in molecular medicine.

[12]  A. Marcus,et al.  Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.

[13]  H. Bellamy,et al.  Structural basis for ligand and heparin binding to neuropilin B domains , 2007, Proceedings of the National Academy of Sciences.

[14]  D. Mukhopadhyay,et al.  Vascular Endothelial Growth Factor and Semaphorin Induce Neuropilin-1 Endocytosis via Separate Pathways , 2008, Circulation research.

[15]  D. Cheresh,et al.  Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. , 2008, Blood.

[16]  E. Ruoslahti,et al.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.

[17]  Erkki Ruoslahti,et al.  Tissue-penetrating delivery of compounds and nanoparticles into tumors. , 2009, Cancer cell.

[18]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.

[19]  T. Ideker,et al.  Functional genomic screen for modulators of ciliogenesis and cilium length , 2010, Nature.

[20]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[21]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[22]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[23]  Tokuko Haraguchi,et al.  Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  C. V. Vander Kooi,et al.  Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1. , 2013, Journal of molecular biology.

[25]  R. Nussinov,et al.  Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. , 2013, Journal of structural biology.

[26]  Erkki Ruoslahti,et al.  Tumor-Penetrating Peptides , 2013, Front. Oncol..

[27]  Erkki Ruoslahti,et al.  Tumor-Penetrating iRGD Peptide Inhibits Metastasis , 2014, Molecular Cancer Therapeutics.

[28]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[29]  Erkki Ruoslahti,et al.  Etchable plasmonic nanoparticle probes to image and quantify cellular internalization , 2014, Nature materials.

[30]  Erkki Ruoslahti,et al.  An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability , 2014, Nature Communications.

[31]  S. Kizaka-Kondoh,et al.  Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[32]  M. Nugent,et al.  Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity* , 2015, The Journal of Biological Chemistry.